Macfarlane K. Angela 4
4 · RenovoRx, Inc. · Filed Jan 30, 2024
Insider Transaction Report
Form 4
RenovoRx, Inc.RNXT
Macfarlane K. Angela
Director
Transactions
- Purchase
Warrant Shares
2024-01-26+40,983→ 40,983 totalExercise: $1.22→ Common Stock (40,983 underlying) - Purchase
Common Stock
2024-01-26+40,983→ 40,983 total
Footnotes (1)
- [F1]Reporting Person purchased 40,983 shares of common stock and warrants to purchase 40,983 shares of common stock for a purchase price of $1.22 per share of common stock and associated warrant exercisable for one share of common stock in a private placement offering by the company made pursuant to Rule 506(c) of the Securities Act of 1933, as amended. The warrants are exercisable immediately, at an exercise price of $1.22 per share, subject to certain adjustments, and expire on January 30, 2029.